KARE/NN
Genomewide/NN
Association/NN
Study/NN
of/IN
Blood/NN
Pressure/NN
Using/VBG
Imputed/JJ
SNPs/NNS
./.
====================
The/DT
imputation/NN
of/IN
untyped/JJ
SNPs/NNS
enables/VBZ
researchers/NNS
to/TO
validate/VB
association/NN
findings/NNS
across/IN
SNP/NN
arrays/NNS
and/CC
also/RB
enables/VBZ
them/PRP
to/TO
test/VB
a/DT
large/JJ
number/NN
of/IN
SNPs/NNS
to/TO
reveal/VB
the/DT
fine/JJ
structure/NN
of/IN
the/DT
association/NN
peak/NN
,/,
facilitating/VBG
interpretation/NN
of/IN
the/DT
results/NNS
and/CC
the/DT
location/NN
of/IN
causal/JJ
polymorphisms/NNS
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
applied/VBD
the/DT
imputation/NN
method/NN
to/TO
a/DT
genomewide/JJ
association/NN
study/NN
and/CC
recapitulated/VBD
the/DT
previously/RB
associated/VBN
gene/NN
loci/NNS
of/IN
blood/NN
pressure/NN
traits/VBZ
in/IN
Korean/JJ
cohorts/NNS
./.
====================
A/DT
total/JJ
of/IN
1,827,004/NN
SNPs/NNS
were/VBD
imputed/VBN
by/IN
the/DT
IMPUTE/NN
program/NN
,/,
and/CC
we/PRP
conducted/VBD
a/DT
genomewide/JJ
association/NN
study/NN
for/IN
systolic/JJ
and/CC
diastolic/JJ
blood/NN
pressure/NN
./.
====================
While/IN
no/DT
SNPs/NNS
passed/VBN
the/DT
Bonferroni/NN
correction/NN
p-value/JJ
(/(
p=2.74×10−8/NN
for/IN
1,827,004/NN
SNPs/NNS
)/)
,/,
12/CD
novel/JJ
loci/NNS
for/IN
systolic/JJ
blood/NN
pressure/NN
and/CC
16/CD
novel/JJ
loci/NNS
for/IN
diastolic/JJ
blood/NN
pressure/NN
were/VBD
detected/VBN
by/IN
imputed/JJ
SNPs/NNS
,/,
with/IN
10−5＜p-value＜10−4/CD
./.
====================
Moreover/RB
,/,
7/CD
regions/NNS
(/(
ATP2B1/NN
,/,
10p15.1/CD
,/,
ARHGEF12/NN
,/,
ALX4/NN
,/,
LIPC/NN
,/,
7q31.1/NN
,/,
and/CC
TCF7L2/NN
)/)
out/RB
of/IN
14/CD
genetic/JJ
loci/NNS
that/IN
were/VBD
previously/RB
reported/VBD
revealed/VBD
that/IN
the/DT
imputed/JJ
SNPs/NNS
had/VBD
lower/JJR
p-values/NNS
than/IN
those/DT
of/IN
genotyped/VBN
SNPs/NNS
./.
====================
Moreover/RB
,/,
a/DT
nonsynonymous/JJ
SNP/NN
in/IN
the/DT
CSMD1/NN
gene/NN
,/,
one/CD
of/IN
the/DT
14/CD
genes/NNS
,/,
was/VBD
found/VBN
to/TO
be/VB
associated/VBN
with/IN
systolic/JJ
blood/NN
pressure/NN
(/(
p＜0.05/NN
)/)
./.
====================
These/DT
results/NNS
suggest/VBP
that/IN
the/DT
imputation/NN
method/NN
can/MD
facilitate/VB
the/DT
discovery/NN
of/IN
novel/JJ
SNPs/NNS
as/IN
well/RB
as/IN
enhance/VBP
the/DT
fine/JJ
structure/NN
of/IN
the/DT
association/NN
peak/NN
in/IN
the/DT
loci/NNS
./.
====================
The/DT
human/JJ
genome/NN
contains/VBZ
~10/CD
million/NN
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
,/,
but/CC
only/RB
a/DT
small/JJ
fraction/NN
of/IN
them/PRP
has/VBZ
been/VBN
assayed/VBN
using/VBG
current/JJ
highdensity/NN
microarrays/NNS
,/,
such/JJ
as/IN
Illumina/NN
and/CC
Affymetrix/JJ
platforms/NNS
./.
====================
To/TO
enhance/VB
an/DT
original/JJ
association/NN
study/NN
,/,
the/DT
genotypes/NNS
of/IN
untyped/JJ
SNPs/NNS
can/MD
be/VB
imputed/VBN
based/VBN
on/IN
nearby/JJ
markers/NNS
and/CC
can/MD
be/VB
tested/VBN
for/IN
association/NN
with/IN
phenotypes/NNS
of/IN
interest/NN
./.
====================
This/DT
strategy/NN
enables/VBZ
researchers/NNS
to/TO
easily/RB
replicate/VBP
and/CC
compare/VBP
previous/JJ
findings/NNS
across/IN
array/NN
types/NNS
and/CC
enables/VBZ
them/PRP
to/TO
test/VB
a/DT
large/JJ
number/NN
of/IN
SNPs/NNS
to/TO
reveal/VB
the/DT
fine/JJ
structure/NN
of/IN
the/DT
association/NN
peak/NN
,/,
facilitating/VBG
interpretation/NN
of/IN
the/DT
results/NNS
and/CC
the/DT
location/NN
of/IN
causal/JJ
polymorphisms/NNS
(/(
Hao/NNP
et/FW
al./FW
,/,
2009/CD
)/)
./.
====================
By/IN
using/VBG
the/DT
imputed/JJ
SNPs/NNS
,/,
Tobin/NN
and/CC
colleagues/NNS
identified/VBD
a/DT
significant/JJ
association/NN
of/IN
the/DT
WNT1/NN
gene/NN
with/IN
diastolic/JJ
blood/NN
pressure/NN
,/,
and/CC
Knouff/JJ
and/CC
colleagues/NNS
identified/VBD
a/DT
significant/JJ
association/NN
between/IN
the/DT
CETP/NN
gene/NN
and/CC
diastolic/JJ
blood/NN
pressure/NN
(/(
Knouff/NNP
et/FW
al./FW
,/,
2008/CD
;/:
Tobin/NN
et/FW
al./FW
,/,
2008/CD
)/)
./.
====================
The/DT
first/JJ
genomewide/NN
association/NN
study/NN
for/IN
large/JJ
cohorts/NNS
in/IN
Korea/NN
was/VBD
conducted/VBN
by/IN
the/DT
Korea/NN
National/JJ
Institute/JJ
of/IN
Health/NN
(/(
KNIH/NN
)/)
and/CC
reported/VBD
associations/NNS
with/IN
8/CD
quantitative/JJ
traits/VBZ
,/,
including/VBG
blood/NN
pressure/NN
(/(
Cho/NNP
et/FW
al./FW
,/,
2009/CD
)/)
./.
====================
The/DT
Korean/JJ
GWAS/NN
suggested/VBD
a/DT
total/JJ
of/IN
14/CD
loci/NNS
for/IN
blood/NN
pressure/NN
,/,
2/CD
(/(
ATP2B1/NN
and/CC
10/CD
p15.1/NN
)/)
of/IN
which/WDT
were/VBD
significant/JJ
association/NN
loci/NNS
(/(
pvalue＜10−5/NN
)/)
;/:
the/DT
remaining/VBG
12/CD
(/(
ARHGEF12/NN
,/,
CSMD1/NN
,/,
ARSG/NN
,/,
SGSM1/NN
,/,
GJA8/NNP
,/,
ALX4/NNP
,/,
2q31.1/NN
,/,
15q22.1/NN
,/,
LIPC/NN
,/,
CSK/NN
,/,
7q21.13/NN
,/,
7q31.1/NN
,/,
10q25.2/CD
)/)
were/VBD
suggestive/JJ
loci/NNS
(/(
10−5＜pvalue＜10−4/CD
)/)
./.
====================
To/TO
enhance/VB
the/DT
original/JJ
association/NN
study/NN
,/,
a/DT
total/JJ
of/IN
1,827,004/NN
imputed/JJ
SNPs/NNS
were/VBD
reanalyzed/VBN
for/IN
their/PRP$
association/NN
with/IN
blood/NN
pressure/NN
in/IN
this/DT
study/NN
./.
====================
Subjects/NNS
and/CC
their/PRP$
genotypes/NNS
were/VBD
reported/VBN
in/IN
a/DT
previous/JJ
genomewide/NN
association/NN
study/NN
(/(
Cho/NN
et/FW
al./FW
,/,
2009/CD
)/)
./.
====================
Briefly/RB
,/,
subjects/NNS
came/VBD
from/IN
2/CD
communitybased/VBD
cohorts/NNS
,/,
the/DT
rural/JJ
community/NN
Ansung/JJ
and/CC
the/DT
urban/JJ
community/NN
Ansan/NN
,/,
in/IN
KyungGiDo/NN
province/NN
,/,
near/JJ
Seoul/JJ
,/,
Korea/NN
./.
====================
Most/JJS
DNA/NN
samples/NNS
were/VBD
isolated/VBN
from/IN
the/DT
peripheral/JJ
blood/NN
of/IN
participants/NNS
and/CC
genotyped/VBD
using/VBG
the/DT
Affymetrix/JJ
Genomewide/NN
Human/JJ
SNP/NN
array/NN
5.0/CD
(/(
Affymetrix/JJ
,/,
Inc./NNP
,/,
Santa/NN
Clara/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
./.
====================
After/IN
the/DT
quality/NN
control/NN
steps/NNS
,/,
we/PRP
finally/RB
used/VBN
7751/CD
individuals/NNS
for/IN
blood/NN
pressure/NN
traits/VBZ
./.
====================
The/DT
351,677/CD
genotyped/VBD
SNPs/NNS
had/VBD
a/DT
missing/JJ
gene/NN
call/JJ
rate/NN
below/IN
0.1/CD
,/,
a/DT
minor/JJ
allele/NN
frequency/NN
(/(
MAF/NN
)/)
higher/JJR
than/IN
0.01/CD
,/,
and/CC
no/DT
deviation/NN
from/IN
Hardy-Weinberg/JJ
Equilibrium/NN
(/(
HWE/NN
)/)
(/(
p＞1×10−6/NN
)/)
(/(
WTCCC/NN
,/,
2007/CD
)/)
./.
====================
The/DT
basic/JJ
characteristics/NNS
and/CC
blood/NN
pressures/NNS
of/IN
the/DT
subjects/NNS
are/VBP
listed/VBN
in/IN
Table/JJ
1/CD
./.
====================
For/IN
this/DT
study/NN
,/,
blood/NN
pressure/NN
measurements/NNS
were/VBD
taken/VBN
3/CD
times/NNS
in/IN
the/DT
supine/NN
position/NN
./.
====================
Before/IN
the/DT
first/JJ
measurement/NN
,/,
participants/NNS
rested/VBD
for/IN
5/CD
minutes/NNS
,/,
and/CC
3/CD
measurements/NNS
were/VBD
made/VBN
at/IN
least/JJS
30/CD
seconds/NNS
apart/VBP
./.
====================
The/DT
average/JJ
of/IN
the/DT
3/CD
measurements/NNS
was/VBD
used/VBN
for/IN
this/DT
study/NN
./.
====================
The/DT
KARE/NN
dataset/NN
,/,
comprising/VBG
351,677/CD
SNPs/NNS
for/IN
7751/CD
individuals/NNS
,/,
was/VBD
merged/VBN
with/IN
that/DT
of/IN
International/JJ
HapMap/NN
Phase/NN
II/CD
JPT/NN
(/(
Japanese/JJ
)/)
+HCB/NN
(/(
Chinese/JJ
)/)
panel/NN
2/CD
./.
====================
The/DT
genotypes/NNS
of/IN
the/DT
KARE/NN
individuals/NNS
were/VBD
imputed/VBN
using/VBG
IMPUTE/NN
(/(
Howie/NNP
et/FW
al./FW
,/,
2009/CD
)/)
./.
====================
Most/JJS
statistical/JJ
analyses/NNS
were/VBD
performed/VBN
using/VBG
PLINK/NN
,/,
version/NN
1.07/CD
(/(
http/NN
:/:
//pngu/FW
./.
====================
mgh/IN
./.
====================
harvard/RB
./.
====================
edu/~purcell/plink//RB
)/)
(/(
Purcell/NN
et/FW
al./FW
,/,
2007/CD
)/)
and/CC
SAS/NN
(/(
version/NN
9.1/CD
;/:
SAS/NN
Institute/JJ
Inc./NNP
,/,
Cary/NN
,/,
NC/NN
,/,
USA/NN
)/)
./.
====================
Systolic/JJ
blood/NN
pressure/NN
(/(
SBP/NN
)/)
and/CC
diastolic/JJ
blood/NN
pressure/NN
(/(
DBP/NN
)/)
were/VBD
tested/VBN
for/IN
their/PRP$
as/IN
sociation/JJ
by/IN
linear/JJ
regression/NN
analysis/NN
with/IN
an/DT
additive/JJ
model/NN
(/(
1-d./JJ
f./FW
)/)
after/IN
adjustments/NNS
for/IN
area/NN
,/,
age/NN
,/,
sex/NN
,/,
and/CC
BMI/NN
./.
====================
Using/VBG
a/DT
filtering/JJ
scheme/NN
of/IN
INFO/NN
≥0.5/CD
and/CC
posterior/JJ
probability/NN
≥0.9/CD
,/,
a/DT
total/JJ
of/IN
1,827,004/NN
SNPs/NNS
were/VBD
imputed/VBN
and/CC
analyzed/VBD
for/IN
the/DT
genomewide/NN
association/NN
study/NN
of/IN
blood/NN
pressure/NN
traits/VBZ
./.
====================
While/IN
no/DT
SNP/NN
passed/VBN
the/DT
Bonferroni/NNP
correction/NN
p-value/JJ
(/(
p=2.74×10−8/NN
for/IN
1,827,004/NN
SNPs/NNS
)/)
,/,
12/CD
novel/JJ
loci/NNS
for/IN
systolic/JJ
blood/NN
pressure/NN
(/(
SBP/NN
)/)
and/CC
16/CD
loci/NNS
for/IN
diastolic/JJ
blood/NN
pressure/NN
(/(
DBP/NN
)/)
were/VBD
detected/VBN
by/IN
the/DT
imputed/JJ
SNPs/NNS
with/IN
10−5＜p-value/JJ
＜10−4/CD
(/(
Table/JJ
2/CD
)/)
./.
====================
Most/JJS
of/IN
the/DT
loci/NNS
had/VBD
lower/JJR
than/IN
2/CD
SNPs/NNS
of/IN
significance/NN
near/JJ
the/DT
region/NN
,/,
except/IN
20q13.13/NN
and/CC
2q33.1/NN
,/,
which/WDT
had/VBD
7/CD
and/CC
6/CD
SNPs/NNS
of/IN
significance/NN
,/,
respectively/RB
./.
====================
Notably/RB
,/,
the/DT
SNP/NN
(/(
rs1027345/NN
)/)
near/JJ
the/DT
ZNF385D/NN
gene/NN
in/IN
the/DT
3p24.3/NN
region/NN
was/VBD
significant/JJ
for/IN
both/DT
SBP/NN
and/CC
DBP/NN
(/(
p=2.06×10−5/NN
and/CC
8.26×10−5/CD
,/,
respectively/RB
)/)
./.
====================
In/IN
order/NN
to/TO
compare/VB
the/DT
signal/NN
p-values/NNS
of/IN
the/DT
imputed/JJ
and/CC
typed/VBD
SNPs/NNS
,/,
SNPs/NNS
that/DT
were/VBD
located/JJ
in/IN
the/DT
14/CD
previously/RB
reported/VBD
genetic/JJ
loci/NNS
in/IN
the/DT
KARE/NN
study/NN
were/VBD
investigated/VBN
(/(
Table/JJ
3/CD
)/)
./.
====================
A/DT
total/JJ
of/IN
7483/CD
SNPs/NNS
were/VBD
extracted/VBN
from/IN
the/DT
1,827,004/NN
imputed/JJ
SNPs/NNS
and/CC
analyzed/VBD
for/IN
blood/NN
pressure/NN
./.
====================
The/DT
most/JJS
significant/JJ
SNPs/NNS
and/CC
their/PRP$
gene/NN
names/NNS
are/VBP
described/VBN
in/IN
Table/JJ
3/CD
./.
====================
For/IN
the/DT
extraction/NN
,/,
the/DT
candidate/NN
regions/NNS
were/VBD
defined/VBN
as±20/NN
kb/NN
for/IN
the/DT
gene/NN
region/NN
and±500/CC
kb/NN
for/IN
the/DT
intergenic/JJ
region/NN
./.
====================
Among/IN
the/DT
14/CD
loci/NNS
,/,
7/CD
loci/NNS
(/(
ATP2B1/NN
,/,
10p15.1/CD
,/,
ARHGEF12/NN
,/,
ALX4/NN
,/,
LIPC/NN
,/,
7q31.1/NN
,/,
and/CC
TCF7L2/NN
)/)
showed/VBD
enhanced/VBN
association/NN
with/IN
blood/NN
pressure/NN
by/IN
the/DT
imputed/JJ
SNPs/NNS
./.
====================
Imputation/NN
methods/NNS
cover/RB
the/DT
candidate/NN
gene/NN
region/NN
densely/RB
,/,
which/WDT
enables/VBZ
one/CD
to/TO
test/VB
a/DT
large/JJ
number/NN
of/IN
SNPs/NNS
to/TO
reveal/VB
the/DT
fine/JJ
structure/NN
of/IN
the/DT
association/NN
peak/NN
./.
====================
The/DT
association/NN
results/NNS
of/IN
the/DT
TCF7L2/NN
gene/NN
could/MD
fall/VB
under/IN
this/DT
case/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
While/IN
only/RB
one/CD
SNP/NN
with/IN
a/DT
p-value/JJ
lower/JJR
than/IN
10−4/CD
was/VBD
present/JJ
in/IN
the/DT
peak/NN
of/IN
the/DT
association/NN
by/IN
the/DT
genotyped/VBN
SNPs/NNS
,/,
the/DT
imputed/JJ
SNPs/NNS
showed/VBD
multiple/JJ
SNPs/NNS
(/(
p-value/JJ
＜10−4/CD
)/)
that/WDT
were/VBD
associated/VBN
around/IN
the/DT
peak/NN
,/,
indicating/VBG
that/IN
the/DT
imputation/NN
methods/NNS
enhance/VBP
the/DT
fine/JJ
structure/NN
of/IN
the/DT
GWAS/NN
results/NNS
./.
====================
Moreover/RB
,/,
6/CD
nonsynonymous/JJ
SNPs/NNS
in/IN
the/DT
14/CD
genes/NNS
were/VBD
identified/VBN
from/IN
the/DT
imputed/JJ
SNPs/NNS
,/,
and/CC
the/DT
rs11984691/NN
of/IN
CSMD1/NN
revealed/VBD
an/DT
association/NN
signal/NN
with/IN
systolic/JJ
pressure/NN
(/(
p-value=0.015/CD
)/)
(/(
Table/JJ
4/CD
)/)
./.
====================
CSMD1/NN
(/(
CUB/NN
and/CC
Sushi/NN
multiple/JJ
domains/NNS
1/CD
)/)
is/VBZ
located/JJ
on/IN
chromosome/NN
8p23.2/NN
and/CC
is/VBZ
known/VBN
as/IN
a/DT
putative/JJ
suppressor/NN
of/IN
squamous/JJ
cell/NN
carcinomas/NNS
of/IN
the/DT
head/JJ
and/CC
neck/NN
(/(
Sun/NN
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
The/DT
gene/NN
encodes/VBZ
a/DT
389-KDa/JJ
transmembrane/JJ
protein/NN
,/,
named/VBN
for/IN
its/PRP$
repeat/NN
CUB/NN
and/CC
sushi/NN
domains/NNS
./.
====================
Both/DT
CUB/NN
and/CC
sushi/NN
domains/NNS
are/VBP
found/VBN
in/IN
many/JJ
other/JJ
proteins/NNS
and/CC
are/VBP
thought/VBN
to/TO
be/VB
sites/NNS
of/IN
either/CC
protein-protein/JJ
or/CC
protein-ligand/CC
interactions/NNS
(/(
Kristiansen/NNP
et/FW
al./FW
,/,
1999/CD
;/:
Lau/NNP
and/CC
Scholnick/NNP
,/,
2003/CD
)/)
./.
====================
The/DT
association/NN
between/IN
the/DT
CSMD1/NN
gene/NN
and/CC
blood/NN
pressure/NN
was/VBD
replicated/VBN
in/IN
our/PRP$
previous/JJ
report/NN
(/(
Hong/JJ
et/FW
al./FW
,/,
2010/CD
)/)
,/,
and/CC
the/DT
nonsynonymous/JJ
rs11984691/NN
might/MD
be/VB
a/DT
causative/JJ
variation/NN
of/IN
the/DT
CSMD1/NN
gene/NN
for/IN
the/DT
regulation/NN
of/IN
blood/NN
pressure/NN
,/,
which/WDT
waits/VBZ
for/IN
its/PRP$
functional/JJ
analysis/NN
in/IN
the/DT
future/JJ
./.
====================
In/IN
conclusion/NN
,/,
a/DT
total/JJ
of/IN
1,827,004/NN
SNPs/NNS
were/VBD
imputed/VBN
based/VBN
on/IN
International/JJ
HapMap/NN
Asian/JJ
data/NNS
,/,
and/CC
a/DT
genomewide/JJ
association/NN
study/NN
of/IN
KARE/NN
for/IN
systolic/JJ
and/CC
diastolic/JJ
blood/NN
pressure/NN
was/VBD
performed/VBN
./.
====================
Even/RB
though/IN
no/DT
SNPs/NNS
were/VBD
found/VBN
to/TO
be/VB
statistically/RB
significant/JJ
over/IN
the/DT
Bonferroni/NN
corrected/VBD
p-value/JJ
,/,
12/CD
novel/JJ
loci/NNS
for/IN
systolic/JJ
blood/NN
pressure/NN
and/CC
16/CD
novel/JJ
loci/NNS
for/IN
diastolic/JJ
blood/NN
pressure/NN
were/VBD
identified/VBN
in/IN
the/DT
range/NN
of/IN
10−5＜p-value＜10−4/CD
./.
====================
Additionally/RB
,/,
the/DT
imputed/JJ
SNPs/NNS
revealed/VBD
better/RBR
p-values/NNS
in/IN
7/CD
out/RP
of/IN
14/CD
genetic/JJ
loci/NNS
that/IN
were/VBD
previously/RB
reported/VBD
by/IN
the/DT
genotyped/VBN
SNPs/NNS
./.
====================
These/DT
results/NNS
suggest/VBP
that/IN
the/DT
imputation/NN
method/NN
can/MD
facilitate/VB
the/DT
discovery/NN
of/IN
associated/VBN
SNPs/NNS
as/IN
well/RB
as/IN
enhance/VBP
the/DT
fine/JJ
structure/NN
of/IN
the/DT
association/NN
in/IN
the/DT
loci/NNS
./.
====================
